Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen.
作者： John L. Marshall , Michael J. Hawkins , Kwong Y. Tsang , Ellen Richmond , James E. Pedicano
DOI: 10.1200/JCO.1999.17.1.332
关键词: MHC class I 、 Immunology 、 CTL* 、 Canarypox Vector 、 Immunotherapy 、 Cancer 、 Virology 、 Peripheral blood mononuclear cell 、 Medicine 、 Carcinoembryonic antigen 、 Recombinant virus
摘要: … Studies were conducted to assess whether ALVAC-CEA had the ability to induce cytolytic T-lymphocyte (CTL) responses in patients with advanced cancer. Peripheral blood …
sci-hub.se 参考文章(29)
R. M. Conry, M. N. Saleh, J. Schlom, A. F. LoBuglio, HUMAN IMMUNE RESPONSE TO CARCINOEMBRYONIC ANTIGEN TUMOR VACCINES Journal of Immunotherapy. ,vol. 18, pp. 137- ,(1995) , 10.1097/00002371-199508000-00048
Ramila Philip, Elisa Brunette, Susan Alters, Jose Gadea, Hui Zheng, Josephine Yau, Jane Lebkowski, Mohan Philip, GENE MODIFIED AND PEPTIDE PULSED DENDRITIC CELLS FOR THE GENERATION OF ACTIVE IMMUNOTHERAPY STRATEGIES Journal of Immunotherapy. ,vol. 19, pp. 467- ,(1996) , 10.1097/00002371-199611000-00053
A. M. Steward, D. Nixon, N. Zamcheck, A. Aisenberg, Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress Cancer. ,vol. 33, pp. 1246- 1252 ,(1974) , 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O
James Tartaglia, Marion E. Perkus, Jill Taylor, Elizabeth K. Norton, Jean-Christophe Audonnet, William I. Cox, Stephen W. Davis, Johanna Van Der Hoeven, Bernard Meignier, Michel Riviere, Bernard Languet, Enzo Paoletti, NYVAC: a highly attenuated strain of vaccinia virus Virology. ,vol. 188, pp. 217- 232 ,(1992) , 10.1016/0042-6822(92)90752-B
J TAYLOR, C TRIMARCHI, R WEINBERG, B LANGUET, F GUILLERMIN, P DESMETTRE, E PAOLETTI, Efficacy studies on a canarypox-rabies recombinant virus. Vaccine. ,vol. 9, pp. 190- 193 ,(1991) , 10.1016/0264-410X(91)90152-V
J. Fagerberg, A. Samanci, Q. Yi, K. Strigård, J-E. Frödin, B. Wahren, U. Rudén, H. Mellstedt, RECOMBINANT CARCINOEMBRYONIC ANTIGEN AND GRANULOCY-TE-MACROPHAGE COLONY-STIMULATING FACTOR FOR ACTIVE IMMUNIZATION OF COLORECTAL CARCINOMA PATIENTS Journal of Immunotherapy. ,vol. 18, pp. 132- ,(1995) , 10.1097/00002371-199508000-00026
Christiane Fuchs, Friedel Krapf, Peter Kern, Suse Hoferichter, Wolfram J�ger, JochenR. Kalden, CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes. Cancer Immunology, Immunotherapy. ,vol. 26, pp. 180- 184 ,(1988) , 10.1007/BF00205613
Susan E. Alters, Jose R. Gadea, Martin Sorich, Gerard O??Donoghue, Sohel Talib, Ramila Philip, Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire. Journal of Immunotherapy. ,vol. 21, pp. 17- 26 ,(1998) , 10.1097/00002371-199801000-00002
J. Kantor, K. Irvine, S. Abrams, H. Kaufman, J. Dipietro, J. Schlom, Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine JNCI Journal of the National Cancer Institute. ,vol. 84, pp. 1084- 1091 ,(1992) , 10.1093/JNCI/84.14.1084
James W. Hodge, Joanne P. McLaughlin, Judith A. Kantor, Jeffrey Schlom, Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses Vaccine. ,vol. 15, pp. 759- 768 ,(1997) , 10.1016/S0264-410X(96)00238-1